Hauser R - Search Results

1

Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment.

Stacy M, Bowron A, Guttman M, Hauser R, Hughes K, Larsen JP, LeWitt P, Oertel W, Quinn N, Sethi K, Stocchi F. Stacy M, et al. Among authors: hauser r. Mov Disord. 2005 Jun;20(6):726-33. doi: 10.1002/mds.20383. Mov Disord. 2005. PMID: 15719426

2

Ropinirole for the treatment of early Parkinson's disease. The Ropinirole Study Group.

Adler CH, Sethi KD, Hauser RA, Davis TL, Hammerstad JP, Bertoni J, Taylor RL, Sanchez-Ramos J, O'Brien CF. Adler CH, et al. Among authors: hauser ra. Neurology. 1997 Aug;49(2):393-9. doi: 10.1212/wnl.49.2.393. Neurology. 1997. PMID: 9270567 Clinical Trial.

3

Sertraline for the treatment of depression in Parkinson's disease.

Hauser RA, Zesiewicz TA. Hauser RA, et al. Mov Disord. 1997 Sep;12(5):756-9. doi: 10.1002/mds.870120522. Mov Disord. 1997. PMID: 9380061 Clinical Trial.

4

Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.

Sethi KD, O'Brien CF, Hammerstad JP, Adler CH, Davis TL, Taylor RL, Sanchez-Ramos J, Bertoni JM, Hauser RA. Sethi KD, et al. Among authors: hauser ra. Arch Neurol. 1998 Sep;55(9):1211-6. doi: 10.1001/archneur.55.9.1211. Arch Neurol. 1998. PMID: 9740115 Clinical Trial.

5

Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.

Hauser RA, Koller WC, Hubble JP, Malapira T, Busenbark K, Olanow CW. Hauser RA, et al. Mov Disord. 2000 May;15(3):485-9. Mov Disord. 2000. PMID: 10830413 Clinical Trial.

6

End-of-dose wearing off in Parkinson disease: a 9-question survey assessment.

Stacy M, Hauser R, Oertel W, Schapira A, Sethi K, Stocchi F, Tolosa E. Stacy M, et al. Among authors: hauser r. Clin Neuropharmacol. 2006 Nov-Dec;29(6):312-21. doi: 10.1097/01.WNF.0000232277.68501.08. Clin Neuropharmacol. 2006. PMID: 17095894

7

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

NINDS NET-PD Investigators. NINDS NET-PD Investigators. Clin Neuropharmacol. 2008 May-Jun;31(3):141-50. doi: 10.1097/WNF.0b013e3181342f32. Clin Neuropharmacol. 2008. PMID: 18520981 Free PMC article. Clinical Trial.

8

Clinical trials of add-on medications in Parkinson's disease: Efficacy versus usefulness.

Hauser RA, Zesiewicz TA, Factor SA, Guttman M, Weiner WJ. Hauser RA, et al. Parkinsonism Relat Disord. 1997 Jan;3(1):1-6. doi: 10.1016/s1353-8020(96)00042-9. Parkinsonism Relat Disord. 1997. PMID: 18591048 Free article.

9

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators. Nichols WC, et al. Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5. Neurology. 2009. PMID: 18987351 Free PMC article.

10

Istradefylline as monotherapy for Parkinson disease: results of the 6002-US-051 trial.

Fernandez HH, Greeley DR, Zweig RM, Wojcieszek J, Mori A, Sussman NM; 6002-US-051 Study Group. Fernandez HH, et al. Parkinsonism Relat Disord. 2010 Jan;16(1):16-20. doi: 10.1016/j.parkreldis.2009.06.008. Epub 2009 Jul 19. Parkinsonism Relat Disord. 2010. PMID: 19616987 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,846 results

Search Page

Filters